{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:28:58Z","timestamp":1791415738670,"version":"4.3.3"},"reference-count":55,"publisher":"China Science Publishing & Media Ltd.","issue":"1","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2015,1,1]]},"DOI":"10.1093\/abbs\/gmu106","type":"journal-article","created":{"date-parts":[[2014,12,5]],"date-time":"2014-12-05T06:29:03Z","timestamp":1417760943000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":41,"title":["The Hippo signaling pathway in liver regeneration and tumorigenesis"],"prefix":"10.3724","volume":"47","author":[{"given":"Lixin","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2015,1,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"e60191","DOI":"10.1371\/journal.pone.0060191","volume":"8","author":"Wang L","year":"2013","unstructured":"Wang L, Li K, Zhang QE, Zeng YW, Jin Z, Dai WJ, Su YA. Interhemispheric functional connectivity and its relationships with clinical characteristics in major depressive disorder: a resting state fMRI study. PloS ONE, 2013, 8:","journal-title":"PloS ONE"},{"key":"null","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrd4161","volume":"13","author":"Johnson R","year":"2013","unstructured":"Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov, 2013, 13: 63-79.","journal-title":"Nat Rev Drug Discov"},{"key":"null","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"Harvey KF","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer, 2013, 13: 246-257.","journal-title":"Nat Rev Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.semcdb.2012.05.004","volume":"23","author":"Hong W","year":"2012","unstructured":"Hong W, Guan KL. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol, 2012, 23: 785-793.","journal-title":"Semin Cell Dev Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.semcdb.2012.05.002","volume":"23","author":"Sudol M","year":"2013","unstructured":"Sudol M, Shields DC, Farooq A. Structures of YAP protein domains reveal promising targets for development of new cancer drugs. Semin Cell Dev Biol, 2013, 23: 827-833.","journal-title":"Semin Cell Dev Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1083\/jcb.141.7.1589","volume":"141","author":"LaJeunesse DR","year":"1998","unstructured":"LaJeunesse DR, McCartney BM, Fehon RG. Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization. J Cell Biol, 1998, 141: 1589-1599.","journal-title":"J Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-56553-3_1","volume":"161","author":"Kmiec Z","year":"2001","unstructured":"Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol, 2001, 161: 1-151.","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.celrep.2013.04.020","volume":"3","author":"Wu H","year":"2013","unstructured":"Wu H, Xiao Y, Zhang S, Ji S, Wei L, Fan F, Geng J. The Ets transcription factor GABP is a component of the Hippo pathway essential for growth and antioxidant defense. Cell Rep, 2013, 3: 1663-1677.","journal-title":"Cell Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"Camargo FD","year":"2007","unstructured":"Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol, 2007, 17: 2054-2060.","journal-title":"Curr Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"Dong J","year":"2007","unstructured":"Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell, 2007, 130: 1120-1133.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","volume":"16","author":"Zhou D","year":"2009","unstructured":"Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell, 2009, 16: 425-438.","journal-title":"Cancer Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.0911409107","volume":"107","author":"Song H","year":"2010","unstructured":"Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA, 2010, 107: 1431-1436.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1073\/pnas.0911427107","volume":"107","author":"Lu L","year":"2010","unstructured":"Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang Y. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA, 2010, 107: 1437-1442.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"8248","DOI":"10.1073\/pnas.0912203107","volume":"107","author":"Lee KP","year":"2010","unstructured":"Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, Kim MC. The Hippo\u2013Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA, 2010, 107: 8248-8253.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1101\/gad.1938710","volume":"24","author":"Benhamouche S","year":"2010","unstructured":"Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Giovannini M, McClatchey AI. Nf2\/merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev, 2010, 24: 1718-1730.","journal-title":"Genes Dev"},{"key":"null","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.devcel.2010.06.015","volume":"19","author":"Zhang N","year":"2010","unstructured":"Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, Giovannini M. The Merlin\/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell, 2010, 19: 27-38.","journal-title":"Dev Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.20969","volume":"43","author":"Fausto N","year":"2006","unstructured":"Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology, 2006, 43: S45-S53.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"G196","DOI":"10.1152\/ajpgi.00077.2014","volume":"307","author":"Grijalva JL","year":"2014","unstructured":"Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol, 2014, 307: G196-G204.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","volume":"157","author":"Yimlamai D","year":"2014","unstructured":"Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K. Hippo pathway activity influences liver cell fate. Cell, 2014, 157: 1324-1338.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbadis.2007.12.004","volume":"1782","author":"Oertel M","year":"2008","unstructured":"Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta, 2008, 1782: 61-74.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/hep.24157","volume":"53","author":"Turner R","year":"2011","unstructured":"Turner R, Lozoya O, Wang Y, Cardinale V, Gaudio E, Alpini G, Mendel G. Human hepatic stem cell and maturational liver lineage biology. Hepatology, 2011, 53: 1035-1045.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2012.08.024","volume":"143","author":"Espanol-Suner R","year":"2012","unstructured":"Espanol-Suner R, Carpentier R, Van Hul N, Legry V, Achouri Y, Cordi S, Jacquemin P. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. e1567. Gastroenterology, 2012, 143: 1564-1575.","journal-title":"Gastroenterology"},{"key":"null","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","volume":"494","author":"Huch M","year":"2013","unstructured":"Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, Sato T. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature, 2013, 494: 247-250.","journal-title":"Nature"},{"key":"null","first-page":"E1312","volume":"108","author":"Zhou D","year":"2011","unstructured":"Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA, 2011, 108: E1312-E1320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1242\/dev.052118","volume":"137","author":"Hofmann JJ","year":"2010","unstructured":"Hofmann JJ, Zovein AC, Koh H, Radtke F, Weinmaster G, Iruela-Arispe ML. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development, 2010, 137: 4061-4072.","journal-title":"Development"},{"key":"null","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1242\/dev.029140","volume":"136","author":"Zong Y","year":"2009","unstructured":"Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, Stanger BZ. Notch signaling controls liver development by regulating biliary differentiation. Development, 2009, 136: 1727-1739.","journal-title":"Development"},{"key":"null","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.20156","volume":"39","author":"Kohler C","year":"2004","unstructured":"Kohler C, Bell AW, Bowen WC, Monga SP, Fleig W, Michalopoulos GK. Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration. Hepatology, 2004, 39: 1056-1065.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"Zhao B","year":"2010","unstructured":"Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev, 2010, 24: 72-85.","journal-title":"Genes Dev"},{"key":"null","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.11.10.1253","volume":"11","author":"McClatchey AI","year":"1997","unstructured":"McClatchey AI, Saotome I, Ramesh V, Gusella JF, Jacks T. The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev, 1997, 11: 1253-1265.","journal-title":"Genes Dev"},{"key":"null","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","volume":"12","author":"McClatchey AI","year":"1998","unstructured":"McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev, 1998, 12: 1121-1133.","journal-title":"Genes Dev"},{"key":"null","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cub.2008.02.006","volume":"18","author":"Praskova M","year":"2008","unstructured":"Praskova M, Xia F, Avruch J. MOBKL1A\/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol, 2008, 18: 311-321.","journal-title":"Curr Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/sj.emboj.7601630","volume":"26","author":"Wei X","year":"2007","unstructured":"Wei X, Shimizu T, Lai ZC. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J, 2007, 26: 1772-1781.","journal-title":"EMBO J"},{"key":"null","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1172\/JCI63735","volume":"122","author":"Nishio M","year":"2012","unstructured":"Nishio M, Hamada K, Kawahara K, Sasaki M, Noguchi F, Chiba S, Mizuno K. Cancer susceptibility and embryonic lethality in Mob1a\/1b double-mutant mice. J Clin Invest, 2012, 122: 4505-4518.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","volume":"125","author":"Zender L","year":"2006","unstructured":"Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell, 2006, 125: 1253-1267.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"12405","DOI":"10.1073\/pnas.0605579103","volume":"103","author":"Overholtzer M","year":"2006","unstructured":"Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA, 2006, 103: 12405-12410.","journal-title":"Proc Natl Acad Sci USA"},{"key":"null","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1002\/cncr.24495","volume":"115","author":"Xu MZ","year":"2009","unstructured":"Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, Zender L, Lowe SW. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer, 2009, 115: 4576-4585.","journal-title":"Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.cdd.4402226","volume":"15","author":"Danovi SA","year":"2008","unstructured":"Danovi SA, Rossi M, Gudmundsdottir K, Yuan M, Melino G, Basu S. Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ, 2008, 15: 217-219.","journal-title":"Cell Death Differ"},{"key":"null","doi-asserted-by":"crossref","first-page":"11730","DOI":"10.1074\/jbc.M111.327767","volume":"287","author":"Konsavage WM","year":"2012","unstructured":"Konsavage WM, Kyler SL, Rennoll SA, Jin G, Yochum GS. Wnt\/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem, 2012, 287: 11730-11739.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/hep.25899","volume":"56","author":"Zhang T","year":"2012","unstructured":"Zhang T, Zhang J, You X, Liu Q, Du Y, Gao Y, Shan C. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology, 2012, 56: 2051-2059.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2010.03.036","volume":"394","author":"Liu AM","year":"2010","unstructured":"Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun, 2010, 394: 623-627.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/hep.26420","volume":"58","author":"Wang J","year":"2013","unstructured":"Wang J, Ma L, Weng W, Qiao Y, Zhang Y, He J, Wang H. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer. Hepatology, 2013, 58: 1011-1020.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1016\/j.febslet.2013.10.042","volume":"587","author":"Li L","year":"2013","unstructured":"Li L, Wang J, Zhang Y, Ma L, Weng W, Qiao Y, Xiao W. MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer. FEBS Lett, 2013, 587: 3921-3927.","journal-title":"FEBS Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1121435","volume":"312","author":"Huang W","year":"2006","unstructured":"Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science, 2006, 312: 233-236.","journal-title":"Science"},{"key":"null","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/carcin\/bgl249","volume":"28","author":"Kim I","year":"2007","unstructured":"Kim I, Morimura K, Shah Y, Yang Q, Ward JM, Gonzalez FJ. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis, 2007, 28: 940-946.","journal-title":"Carcinogenesis"},{"key":"null","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","volume":"67","author":"Yang F","year":"2007","unstructured":"Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res, 2007, 67: 863-867.","journal-title":"Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI42846","volume":"121","author":"Anakk S","year":"2011","unstructured":"Anakk S, Watanabe M, Ochsner SA, McKenna NJ, Finegold MJ, Moore DD. Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis. J Clin Invest, 2011, 121: 86-95.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.celrep.2013.10.030","volume":"5","author":"Anakk S","year":"2013","unstructured":"Anakk S, Bhosale M, Schmidt VA, Johnson RL, Finegold MJ, Moore DD. Bile acids activate YAP to promote liver carcinogenesis. Cell Rep, 2013, 5: 1060-1069.","journal-title":"Cell Rep"},{"key":"null","first-page":"pe27","volume":"6","author":"Hong W","year":"2013","unstructured":"Hong W. Angiomotin'g YAP into the nucleus for cell proliferation and cancer development. Sci Signal, 2013, 6:","journal-title":"Sci Signal"},{"key":"null","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1091\/mbc.e11-04-0300","volume":"22","author":"Paramasivam M","year":"2011","unstructured":"Paramasivam M, Sarkeshik A, Yates JR, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell, 2011, 22: 3725-3733.","journal-title":"Mol Biol Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1074\/jbc.C110.212621","volume":"286","author":"Chan SW","year":"2011","unstructured":"Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem, 2011, 286: 7018-7026.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1101\/gad.2000111","volume":"25","author":"Zhao B","year":"2011","unstructured":"Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, Guan KL. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev, 2011, 25: 51-63.","journal-title":"Genes Dev"},{"key":"null","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1074\/jbc.C110.205401","volume":"286","author":"Wang W","year":"2011","unstructured":"Wang W, Huang J, Chen J. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem, 2011, 286: 4364-4370.","journal-title":"J Biol Chem"},{"key":"null","first-page":"ra77","volume":"6","author":"Yi C","year":"2013","unstructured":"Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, Liu Q. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal, 2013, 6:","journal-title":"Sci Signal"},{"key":"null","doi-asserted-by":"crossref","first-page":"22089","DOI":"10.1074\/jbc.M111.334714","volume":"287","author":"Hata S","year":"2012","unstructured":"Hata S, Hirayama J, Kajiho H, Nakagawa K, Hata Y, Katada T, Furutani-Seiki M. A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents. J Biol Chem, 2012, 287: 22089-22098.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/onc.2013.88","volume":"33","author":"Mao B","year":"2014","unstructured":"Mao B, Hu F, Cheng J, Wang P, Xu M, Yuan F, Meng S. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma. Oncogene, 2014, 33: 1468-1474.","journal-title":"Oncogene"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/5BF1DDA42BD446D386C1FD375FD3E3FA","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmu106","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/5BF1DDA42BD446D386C1FD375FD3E3FA","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T13:09:55Z","timestamp":1690722595000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmu106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,1]]},"published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmu106","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}